| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.02049-10 |
| P8608 | Fatcat ID | release_erulm376prhv5lo4ruhoehcspe |
| P932 | PMC publication ID | 3067873 |
| P698 | PubMed publication ID | 21270145 |
| P5875 | ResearchGate publication ID | 49788162 |
| P2093 | author name string | Xiaojun Wang | |
| Ying Dang | |||
| Aierken Abudu | |||
| Patrick J Venta | |||
| Sungmo Son | |||
| Yong-Hui Zheng | |||
| P2860 | cites work | Population stratification of a common APOBEC gene deletion polymorphism | Q21563457 |
| A Draft Sequence of the Neandertal Genome | Q22065895 | ||
| The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA | Q24305266 | ||
| Antiretroelement activity of APOBEC3H was lost twice in recent human evolution | Q24311460 | ||
| Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. | Q24311896 | ||
| Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1 | Q24317568 | ||
| Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication | Q24563503 | ||
| A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins | Q24564187 | ||
| The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity | Q24596322 | ||
| A complete Neandertal mitochondrial genome sequence determined by high-throughput sequencing | Q24645190 | ||
| Human cytidine deaminase APOBEC3H restricts HIV-1 replication | Q24653682 | ||
| The range of human APOBEC3H sensitivity to lentiviral Vif proteins | Q24653931 | ||
| Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H | Q24655418 | ||
| A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity | Q24656551 | ||
| Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication | Q24669993 | ||
| Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family | Q24670173 | ||
| Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation | Q24672209 | ||
| All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition | Q24675735 | ||
| A haplotype map of the human genome | Q24679827 | ||
| Database resources of the National Center for Biotechnology Information | Q24683601 | ||
| Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration | Q24684279 | ||
| Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 | ||
| Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts | Q28179446 | ||
| DNA deamination mediates innate immunity to retroviral infection | Q28179534 | ||
| Hypermutation of HIV-1 DNA in the Absence of the Vif Protein | Q28204475 | ||
| HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability | Q28207304 | ||
| Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex | Q28210666 | ||
| Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging | Q28260455 | ||
| RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1 | Q28474904 | ||
| Cytidine deamination of retroviral DNA by diverse APOBEC proteins | Q28578747 | ||
| HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation | Q29618937 | ||
| The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif | Q29618938 | ||
| Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development. | Q30381745 | ||
| APOBEC3G inhibits elongation of HIV-1 reverse transcripts | Q33389841 | ||
| Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication | Q33825197 | ||
| APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms. | Q33826968 | ||
| Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity | Q34045987 | ||
| Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant | Q35947586 | ||
| Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. | Q37099784 | ||
| Human cellular restriction factors that target HIV-1 replication | Q37382519 | ||
| Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif. | Q37655426 | ||
| Inference of haplotypes from PCR-amplified samples of diploid populations | Q37810133 | ||
| HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation | Q45195765 | ||
| Complementary function of the two catalytic domains of APOBEC3G. | Q45274484 | ||
| Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. | Q52051237 | ||
| Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. | Q53852671 | ||
| High-resolution haplotype structure in the human genome | Q56002085 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3142-3152 | |
| P577 | publication date | 2011-01-26 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity | |
| P478 | volume | 85 |
| Q33651576 | A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif. |
| Q55092316 | AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates. |
| Q91063353 | APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma |
| Q36031782 | APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans |
| Q92006340 | APOBEC3A is a prominent cytidine deaminase in breast cancer |
| Q24310242 | APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1 |
| Q36811931 | APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication |
| Q59352474 | APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction |
| Q40913460 | APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population |
| Q38394187 | APOBECs and virus restriction |
| Q26781812 | Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review) |
| Q40618088 | Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification |
| Q28657772 | Cellular superspreaders: an epidemiological perspective on HIV infection inside the body |
| Q61446131 | Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa |
| Q34261416 | Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation |
| Q33558327 | Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization. |
| Q41539251 | Deamination-independent restriction of LINE-1 retrotransposition by APOBEC3H |
| Q42041441 | Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution |
| Q28481286 | Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n |
| Q47152216 | Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B. |
| Q28548089 | Extremely High Mutation Rate of HIV-1 In Vivo |
| Q40212174 | Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins |
| Q54237606 | Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV? |
| Q90440645 | Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity |
| Q57295397 | Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease |
| Q33699581 | HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation |
| Q36548179 | Host restriction factors in retroviral infection: promises in virus-host interaction |
| Q33982561 | Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection |
| Q24321636 | Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1 |
| Q43076222 | Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations |
| Q39155683 | Lentivirus restriction by diverse primate APOBEC3A proteins |
| Q37593180 | Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G. |
| Q26823568 | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all |
| Q47555946 | Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature |
| Q60044560 | Natural APOBEC3C variants can elicit differential HIV-1 restriction activity |
| Q36283884 | Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability. |
| Q21144862 | Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity |
| Q41900176 | Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity |
| Q93194984 | Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies |
| Q38879828 | Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections |
| Q58583800 | RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids |
| Q59358404 | Recurrent Loss of APOBEC3H Activity during Primate Evolution |
| Q31078477 | Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities |
| Q36162443 | Retroelements versus APOBEC3 family members: No great escape from the magnificent seven |
| Q47553808 | Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients |
| Q64109172 | Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance |
| Q36432758 | Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein |
| Q35068754 | Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities |
| Q47265189 | Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans. |
| Q59355711 | Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA |
| Q36724272 | Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination. |
| Q27025150 | Suppression of APOBEC3-mediated restriction of HIV-1 by Vif |
| Q26862780 | The APOBEC3 family of retroelement restriction factors |
| Q47207734 | The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism. |
| Q37281847 | The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis. |
| Q39056653 | The Structural Interface between HIV-1 Vif and Human APOBEC3H. |
| Q35666084 | The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H |
| Q34612416 | The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif. |
| Q24605108 | The restriction factors of human immunodeficiency virus |
| Q41812539 | The role of cytidine deaminases on innate immune responses against human viral infections. |
| Q47548056 | Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control |
| Q52371380 | Understanding the Structure, Multimerization, Subcellular Localization and mC Selectivity of a Genomic Mutator and Anti-HIV Factor APOBEC3H. |
Search more.